These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art. Kwon DH; Desai MY Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):103-11. PubMed ID: 20014937 [TBL] [Abstract][Full Text] [Related]
9. My approach to clinical management of hypertrophic cardiomyopathy. Maron MS Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674 [No Abstract] [Full Text] [Related]
10. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Olivotto I; Cecchi F; Poggesi C; Yacoub MH Circ Heart Fail; 2012 Jul; 5(4):535-46. PubMed ID: 22811549 [No Abstract] [Full Text] [Related]
11. Risk stratification in hypertrophic cardiomyopathy: time for renewal? Pacileo G; Salerno G; Gravino R; Calabrò R; Elliott PM J Cardiovasc Med (Hagerstown); 2013 May; 14(5):319-25. PubMed ID: 22885536 [TBL] [Abstract][Full Text] [Related]
12. Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy. Maron BJ; Haas TS; Lesser JR Circulation; 2007 Jun; 115(24):e627-8. PubMed ID: 17576874 [No Abstract] [Full Text] [Related]
13. [Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - yes]. Thanaraj A; Meder B Dtsch Med Wochenschr; 2013 Mar; 138(12):598. PubMed ID: 23483421 [No Abstract] [Full Text] [Related]
14. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging. Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422 [TBL] [Abstract][Full Text] [Related]
15. MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances. Hansen MW; Merchant N AJR Am J Roentgenol; 2007 Dec; 189(6):1344-52. PubMed ID: 18029870 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance. Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443 [TBL] [Abstract][Full Text] [Related]
18. [Contribution of magnetic resonance imaging to the diagnosis of 2 cases of cardiomyopathy]. Zerbo F; Fiore D; Bressan M; Dalla Volta S Cardiologia; 1994 Oct; 39(10):737-40. PubMed ID: 7882396 [TBL] [Abstract][Full Text] [Related]
19. [The contribution of molecular genetics to clinical cardiology: the example of hypertrophic cardiomyopathy]. Fokstuen S; Blouin JL; Lyle R; Lerch R; Beghetti M; Mach F; Sztajzel J; Antonarakis SE; Sigwart U Rev Med Suisse; 2005 May; 1(21):1448, 1450, 1452-3. PubMed ID: 15997984 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. Bos JM; Towbin JA; Ackerman MJ J Am Coll Cardiol; 2009 Jul; 54(3):201-11. PubMed ID: 19589432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]